Back to mobile site

Zai Lab Announces Presentations at June Conferences

May 29, 2019 7:30 AM EDT

SHANGHAI, China, May 29, 2019 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced that members of the senior management team will be attending the following upcoming conferences in June. Details of the conferences are as follows: 

Jefferies 2019 Healthcare ConferencePresentation: Wednesday, June 5, 2019 at 4:00 p.m. EDTPresenter: Tao Fu, President & Chief Operating Officer Location: New York

Credit Suisse Asia Healthcare Corporate DaysPresentation: Thursday, June 6, 2019 at 9:00 a.m. CSTPresenter: Billy Cho, Chief Financial Officer Location: Hong Kong

Citi 8th Annual European Healthcare ConferenceDate: June 18-19, 2019Location: London

Individuals may access a live webcast of the Jefferies 2019 Healthcare Conference presentation on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investor Relations" section.  A replay of the webcast will be available on this site for 30 days following the live event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB) is a China and US-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide.

Contact:

Zai LabBilly Cho, CFO+86 137 6151 2501 [email protected]

Media: Nancie Steinberg / Robert FlammBurns McClellan, on behalf of Zai Lab212-213-0006, ext. 318 / 364, [email protected] / [email protected]

Investors: Lee RothBurns McClellan, on behalf of Zai Lab212-213-0006, ext. 331, [email protected]

Zai Lab logo .png

Source: Zai Lab Limited


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases

Related Entities

Credit Suisse, Citi, Jefferies & Co